FairJourney Biologics, S.A.
FairJourney Biologics, S.A., commonly referred to as FJBio, is a leading biotechnology company headquartered in Portugal (PT). Founded in 2012, the company has established itself as a key player in the biopharmaceutical industry, focusing on the discovery and development of innovative therapeutic antibodies. With operational reach extending across Europe and North America, FairJourney Biologics is renowned for its cutting-edge services in antibody engineering and optimisation. The company’s core offerings include a proprietary platform for antibody discovery, which sets it apart through its efficiency and precision. FairJourney Biologics has achieved significant milestones, including collaborations with major pharmaceutical firms, solidifying its position in the competitive biotech landscape. With a commitment to advancing healthcare solutions, FJBio continues to drive innovation in the field of biologics.
DitchCarbon Score
How does FairJourney Biologics, S.A.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
FairJourney Biologics, S.A.'s score of 23 is lower than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
FairJourney Biologics, S.A.'s reported carbon emissions
FairJourney Biologics, S.A., headquartered in Portugal (PT), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As a result, FairJourney Biologics does not have any publicly available commitments or initiatives aimed at reducing carbon emissions or addressing climate change. This lack of data may reflect a broader industry context where companies are increasingly expected to disclose their environmental impact and set ambitious sustainability goals. Without specific emissions data or reduction initiatives, it is challenging to assess FairJourney Biologics' position in the context of climate commitments.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
FairJourney Biologics, S.A. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
